Sphingolipid metabolism-related genes for the diagnosis of metabolic syndrome by integrated bioinformatics analysis and Mendelian randomization identification
Abstract Background The rising global incidence of metabolic syndrome (MetS) highlights the need for more effective diagnostic and therapeutic tools. Sphingolipid metabolites are crucial in MetS pathogenesis, and identifying related biomarkers could improve treatment strategies. Methods Differential...
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-06-01
|
| Series: | Diabetology & Metabolic Syndrome |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13098-025-01803-8 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850111708402548736 |
|---|---|
| author | Weidong Li Qixing Zhong Naisheng Deng Xinhao Zhou Haitao Wang Jun Ouyang Zhifen Guan Bohao Cheng Lijun Xiang Yueming Huang Yao Wang |
| author_facet | Weidong Li Qixing Zhong Naisheng Deng Xinhao Zhou Haitao Wang Jun Ouyang Zhifen Guan Bohao Cheng Lijun Xiang Yueming Huang Yao Wang |
| author_sort | Weidong Li |
| collection | DOAJ |
| description | Abstract Background The rising global incidence of metabolic syndrome (MetS) highlights the need for more effective diagnostic and therapeutic tools. Sphingolipid metabolites are crucial in MetS pathogenesis, and identifying related biomarkers could improve treatment strategies. Methods Differentially expressed genes (DEGs) were extracted from the GSE181646 dataset and compared with sphingolipid metabolism-related genes (SMRGs) to identify differentially expressed SMRGs (DE-SMRGs). Key module genes were obtained via Weighted Gene Co-expression Network Analysis (WGCNA). Machine learning and receiver operating characteristic (ROC) curve validation were used to screen biomarkers, followed by Gene Set Enrichment Analysis (GSEA) and immune cell infiltration analysis. Mendelian randomization (MR) was conducted to explore causal relationships between biomarkers and MetS-related diseases. Results A total of 701 DEGs, 599 key module genes, and 30 candidate genes were identified. PTPN18 and TAX1BP3 were validated as biomarkers and were found to be enriched in neuroactive ligand-receptor interactions and vascular smooth muscle contraction pathways. The levels of five immune cell types, including plasmacytoid dendritic cells, exhibited notable differences between the MetS and normal samples. TAX1BP3 exhibited a markedly negative correlation with activated CD8 T cell (r = -0.584), whereas it showed a markedly positive correlation with plasmacytoid dendritic cells (r = 0.744). MR analysis revealed that PTPN18 acted as a protective factor against obesity (P < 0.05, OR = 0.702), hyperlipidemia (P = 0.0015, OR = 0.855), and type 2 diabetes (P = 0.0026, OR = 0.953), but was associated with elevated fasting blood insulin (P < 0.05, OR = 1.036). Conclusion PTPN18 and TAX1BP3 were identified as sphingolipid metabolism-related biomarkers for MetS, offering potential promising targets for therapeutic intervention. |
| format | Article |
| id | doaj-art-d27246a3f54b47b9a83cdc3d08d2c99f |
| institution | OA Journals |
| issn | 1758-5996 |
| language | English |
| publishDate | 2025-06-01 |
| publisher | BMC |
| record_format | Article |
| series | Diabetology & Metabolic Syndrome |
| spelling | doaj-art-d27246a3f54b47b9a83cdc3d08d2c99f2025-08-20T02:37:33ZengBMCDiabetology & Metabolic Syndrome1758-59962025-06-0117111710.1186/s13098-025-01803-8Sphingolipid metabolism-related genes for the diagnosis of metabolic syndrome by integrated bioinformatics analysis and Mendelian randomization identificationWeidong Li0Qixing Zhong1Naisheng Deng2Xinhao Zhou3Haitao Wang4Jun Ouyang5Zhifen Guan6Bohao Cheng7Lijun Xiang8Yueming Huang9Yao Wang10Department of Gastrointestinal Surgery, Zhongshan City People’s HospitalDepartment of Gastrointestinal Surgery, Zhongshan City People’s HospitalDepartment of Gastrointestinal Surgery, Zhongshan City People’s HospitalDepartment of Gastrointestinal Surgery, Zhongshan City People’s HospitalDepartment of Gastrointestinal Surgery, Zhongshan City People’s HospitalDepartment of Gastrointestinal Surgery, Zhongshan City People’s HospitalDepartment of Gastrointestinal Surgery, Zhongshan City People’s HospitalDepartment of Gastrointestinal Surgery, Zhongshan City People’s HospitalDepartment of Gastrointestinal Surgery, Zhongshan City People’s HospitalDepartment of Gastrointestinal Surgery, Zhongshan City People’s HospitalDepartment of Gastrointestinal Surgery, Zhongshan City People’s HospitalAbstract Background The rising global incidence of metabolic syndrome (MetS) highlights the need for more effective diagnostic and therapeutic tools. Sphingolipid metabolites are crucial in MetS pathogenesis, and identifying related biomarkers could improve treatment strategies. Methods Differentially expressed genes (DEGs) were extracted from the GSE181646 dataset and compared with sphingolipid metabolism-related genes (SMRGs) to identify differentially expressed SMRGs (DE-SMRGs). Key module genes were obtained via Weighted Gene Co-expression Network Analysis (WGCNA). Machine learning and receiver operating characteristic (ROC) curve validation were used to screen biomarkers, followed by Gene Set Enrichment Analysis (GSEA) and immune cell infiltration analysis. Mendelian randomization (MR) was conducted to explore causal relationships between biomarkers and MetS-related diseases. Results A total of 701 DEGs, 599 key module genes, and 30 candidate genes were identified. PTPN18 and TAX1BP3 were validated as biomarkers and were found to be enriched in neuroactive ligand-receptor interactions and vascular smooth muscle contraction pathways. The levels of five immune cell types, including plasmacytoid dendritic cells, exhibited notable differences between the MetS and normal samples. TAX1BP3 exhibited a markedly negative correlation with activated CD8 T cell (r = -0.584), whereas it showed a markedly positive correlation with plasmacytoid dendritic cells (r = 0.744). MR analysis revealed that PTPN18 acted as a protective factor against obesity (P < 0.05, OR = 0.702), hyperlipidemia (P = 0.0015, OR = 0.855), and type 2 diabetes (P = 0.0026, OR = 0.953), but was associated with elevated fasting blood insulin (P < 0.05, OR = 1.036). Conclusion PTPN18 and TAX1BP3 were identified as sphingolipid metabolism-related biomarkers for MetS, offering potential promising targets for therapeutic intervention.https://doi.org/10.1186/s13098-025-01803-8Metabolic syndromeSphingolipid metabolismPTPN18 and TAX1BP3Mendelian randomizationKey module genes |
| spellingShingle | Weidong Li Qixing Zhong Naisheng Deng Xinhao Zhou Haitao Wang Jun Ouyang Zhifen Guan Bohao Cheng Lijun Xiang Yueming Huang Yao Wang Sphingolipid metabolism-related genes for the diagnosis of metabolic syndrome by integrated bioinformatics analysis and Mendelian randomization identification Diabetology & Metabolic Syndrome Metabolic syndrome Sphingolipid metabolism PTPN18 and TAX1BP3 Mendelian randomization Key module genes |
| title | Sphingolipid metabolism-related genes for the diagnosis of metabolic syndrome by integrated bioinformatics analysis and Mendelian randomization identification |
| title_full | Sphingolipid metabolism-related genes for the diagnosis of metabolic syndrome by integrated bioinformatics analysis and Mendelian randomization identification |
| title_fullStr | Sphingolipid metabolism-related genes for the diagnosis of metabolic syndrome by integrated bioinformatics analysis and Mendelian randomization identification |
| title_full_unstemmed | Sphingolipid metabolism-related genes for the diagnosis of metabolic syndrome by integrated bioinformatics analysis and Mendelian randomization identification |
| title_short | Sphingolipid metabolism-related genes for the diagnosis of metabolic syndrome by integrated bioinformatics analysis and Mendelian randomization identification |
| title_sort | sphingolipid metabolism related genes for the diagnosis of metabolic syndrome by integrated bioinformatics analysis and mendelian randomization identification |
| topic | Metabolic syndrome Sphingolipid metabolism PTPN18 and TAX1BP3 Mendelian randomization Key module genes |
| url | https://doi.org/10.1186/s13098-025-01803-8 |
| work_keys_str_mv | AT weidongli sphingolipidmetabolismrelatedgenesforthediagnosisofmetabolicsyndromebyintegratedbioinformaticsanalysisandmendelianrandomizationidentification AT qixingzhong sphingolipidmetabolismrelatedgenesforthediagnosisofmetabolicsyndromebyintegratedbioinformaticsanalysisandmendelianrandomizationidentification AT naishengdeng sphingolipidmetabolismrelatedgenesforthediagnosisofmetabolicsyndromebyintegratedbioinformaticsanalysisandmendelianrandomizationidentification AT xinhaozhou sphingolipidmetabolismrelatedgenesforthediagnosisofmetabolicsyndromebyintegratedbioinformaticsanalysisandmendelianrandomizationidentification AT haitaowang sphingolipidmetabolismrelatedgenesforthediagnosisofmetabolicsyndromebyintegratedbioinformaticsanalysisandmendelianrandomizationidentification AT junouyang sphingolipidmetabolismrelatedgenesforthediagnosisofmetabolicsyndromebyintegratedbioinformaticsanalysisandmendelianrandomizationidentification AT zhifenguan sphingolipidmetabolismrelatedgenesforthediagnosisofmetabolicsyndromebyintegratedbioinformaticsanalysisandmendelianrandomizationidentification AT bohaocheng sphingolipidmetabolismrelatedgenesforthediagnosisofmetabolicsyndromebyintegratedbioinformaticsanalysisandmendelianrandomizationidentification AT lijunxiang sphingolipidmetabolismrelatedgenesforthediagnosisofmetabolicsyndromebyintegratedbioinformaticsanalysisandmendelianrandomizationidentification AT yueminghuang sphingolipidmetabolismrelatedgenesforthediagnosisofmetabolicsyndromebyintegratedbioinformaticsanalysisandmendelianrandomizationidentification AT yaowang sphingolipidmetabolismrelatedgenesforthediagnosisofmetabolicsyndromebyintegratedbioinformaticsanalysisandmendelianrandomizationidentification |